Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma

Before the sorafenib era, advanced but liver-confined hepatocellular carcinoma (HCC) was treated by liver-directed therapy. Hepatic arterial concurrent chemoradiotherapy (CCRT) has been performed in our group, giving substantial local control but frequent failure. The aim of this study was to analyz...

Descripción completa

Detalles Bibliográficos
Autores principales: Cha, Hyejung, Yoon, Hong In, Lee, Ik Jae, Koom, Woong Sub, Han, Kwang-Hyub, Seong, Jinsil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823771/
https://www.ncbi.nlm.nih.gov/pubmed/23633620
http://dx.doi.org/10.1093/jrr/rrt034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823771/
https://www.ncbi.nlm.nih.gov/pubmed/23633620
http://dx.doi.org/10.1093/jrr/rrt034

Ejemplares similares